Jie Chen, Jing Lu, Qingyi Wang, Chu Chu, Linghui Zeng, Jie Zhao
{"title":"[Research progress of metalloporphyrin against neurodegene-rative diseases].","authors":"Jie Chen, Jing Lu, Qingyi Wang, Chu Chu, Linghui Zeng, Jie Zhao","doi":"10.3724/zdxbyxb-2024-0208","DOIUrl":null,"url":null,"abstract":"<p><p>Neurodegenerative diseases are a group of diseases caused by the degeneration and apoptosis of neurons in the brain and spinal cord, which seriously affect human ability of motion perception, memory and cognition. Peroxynitrite can cause oxidative damage in the brain by exhibiting neurotoxicity, and its excessive accumulation is closely related to neurodegenerative diseases. Therefore, effectively scavenging peroxynitrite may become a therapeutic strategy for neurodegenerative diseases. Due to their high peroxynitrite scavenging ability, water-soluble metalloporphyrins have recently attracted much attention. Metalloporphyrins such as iron porphyrins and manganese porphyrins have neuroprotective effects, including inhibiting amyloid plaque accumulation, alleviating oxidative stress and neuroinflammatory damage, improving mitochondrial function and reducing neuronal apoptosis. However, some metalloporphyrins have poor blood-brain barrier penetration. To overcome this obstacle, in addition to traditional synthesis processes, metalloporphyrins can also be prepared into nanoparticles to improve bioavailability <i>in vivo</i>. Here, we will review the mechanisms underlying the neuroprotective effects of metalloporphyrins and explore their therapeutic potential for neurodegenerative diseases.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"81-89"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11956865/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3724/zdxbyxb-2024-0208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Neurodegenerative diseases are a group of diseases caused by the degeneration and apoptosis of neurons in the brain and spinal cord, which seriously affect human ability of motion perception, memory and cognition. Peroxynitrite can cause oxidative damage in the brain by exhibiting neurotoxicity, and its excessive accumulation is closely related to neurodegenerative diseases. Therefore, effectively scavenging peroxynitrite may become a therapeutic strategy for neurodegenerative diseases. Due to their high peroxynitrite scavenging ability, water-soluble metalloporphyrins have recently attracted much attention. Metalloporphyrins such as iron porphyrins and manganese porphyrins have neuroprotective effects, including inhibiting amyloid plaque accumulation, alleviating oxidative stress and neuroinflammatory damage, improving mitochondrial function and reducing neuronal apoptosis. However, some metalloporphyrins have poor blood-brain barrier penetration. To overcome this obstacle, in addition to traditional synthesis processes, metalloporphyrins can also be prepared into nanoparticles to improve bioavailability in vivo. Here, we will review the mechanisms underlying the neuroprotective effects of metalloporphyrins and explore their therapeutic potential for neurodegenerative diseases.